Jacob Moran-Gilad
Overview
Explore the profile of Jacob Moran-Gilad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
1245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yagel Y, Motro Y, Green S, Klapper-Goldstein H, Pardo E, Moran-Gilad J, et al.
Arch Gynecol Obstet
. 2025 Mar;
PMID: 40082312
Objective: To describe the microbiome of the vagina and fallopian tubes (FT) and its relation with hydrosalpinx. Methods: Case-control study was conducted in women who underwent salpingectomy for hydrosalpinx (case)...
2.
Marano R, Oster Y, Benenson S, Motro Y, Ayalon O, Rosenbluh C, et al.
J Infect Dis
. 2025 Mar;
PMID: 40036400
Carbapenemase-producing Enterobacterales (CPE) pose a major healthcare challenge. We report the first hospital outbreak of Pseudocitrobacter faecalis carrying blaNDM-1 using an omics-based approach. Short- and long-read sequencing enabled genomic epidemiological...
3.
Lapid R, Motro Y, Craddock H, Salah I, King R, Winner K, et al.
mSphere
. 2025 Feb;
:e0081924.
PMID: 39945541
Importance: The research highlights the potential role of the golden jackals as reservoirs for antimicrobial resistance (AMR). The high prevalence of clinically relevant AMR genes in these jackals emphasizes the...
4.
Sewell M, Farley C, Portal E, Lindsay D, Ricci M, Jarraud S, et al.
J Microbiol Methods
. 2024 Dec;
228():107071.
PMID: 39706371
Currently there is no detailed, internationally agreed protocol defined to evaluate antimicrobial susceptibility testing (AST) for Legionella pneumophila (required to establish epidemiological cut-off value or "ECOFF" boundaries); therefore, antimicrobial resistance...
5.
Mathur S, Salah I, Msarwa H, Craddock H, Moran-Gilad J
Lett Appl Microbiol
. 2024 Dec;
78(1).
PMID: 39701809
This study evaluated a point-of-care device for wastewater-based epidemiology (WBE) of SARS-CoV-2 circulation. WBE is a critical tool but faces challenges such as laboratory infrastructure, sample transport, skilled personnel, and...
6.
Avni D, Solomon M, Strauss M, Sagi O, Temper V, Michael-Gayego A, et al.
Microorganisms
. 2024 Oct;
12(10).
PMID: 39458260
Background: Leishmaniasis, mainly cutaneous leishmaniasis (CL), is endemic in Israel. In recent years, the diagnosis of leishmaniasis has transitioned to a molecular diagnosis. Objective: To summarize all cases of leishmaniasis...
7.
Harari A, Kaniel O, Keshet R, Shaish A, Kessler Y, Szold A, et al.
Nutrients
. 2024 Aug;
16(16).
PMID: 39203733
Given the health benefits of carotenoids, it is crucial to evaluate their levels in patients undergoing malabsorptive procedures like one anastomosis gastric bypass (OAGB). This study aimed to assess serum...
8.
Strahilevitz J, Motro Y, Temper V, Merezhko D, Ayalon O, Bar Moshe Y, et al.
Antimicrob Agents Chemother
. 2024 Jul;
68(8):e0066324.
PMID: 38990012
Non-carbapenemase-producing carbapenem-resistant (non-CP CRE) may be associated with a grave outcome. The common underlying mechanism is beta-lactamases and mutations in outer membrane porins. We report a case of a deep-seated...
9.
Motro Y, Temper V, Strahilevitz J, Moran-Gilad J
Eur J Clin Microbiol Infect Dis
. 2024 May;
43(8):1645-1650.
PMID: 38811483
E. innesii is a recently described Enterococcus species which may be difficult to differentiate from the more common E. casseliflavus. We present the first clinical report of invasive E. innesii...
10.
Huggett J, OSullivan D, Cowen S, Cleveland M, Davies K, Harris K, et al.
Mol Aspects Med
. 2024 May;
97:101275.
PMID: 38772082
Diagnostic tests were heralded as crucial during the Coronavirus disease (COVID-19) pandemic with most of the key methods using bioanalytical approaches that detected larger molecules (RNA, protein antigens or antibodies)...